Approval Expanded for Breast Cancer Drug Tykerb
Links shared publicly online about this topic.
- 1,413total visits
Approval Expanded for Breast Cancer Drug Tykerb
View full resource at news.healingwell.com
Tags: Cancer, Cancer Medication, Breast Cancer, Breast Cancer Medication, Drug, Women's Health
Most Recently Shared on February 1, 2010 at 7:41 pm By:
Approval Expanded for Breast Cancer Drug Tykerb news http://bit.ly/9vZJnd #breastcancer
TYKERB (Lapatinib) drug information from MPR
empr.com — “TYKERB (Lapatinib) drug information for Cancer, breast, Neoplasms from MPR including side effects, drug interactions, dosing, contraindications and precautions.” View full resource at empr.com
Most Recently Shared on April 27, 2010 at 4:14 am By:
MPR News: TYKERB: Indications: approved for use in combination with letrozole. Adults: dosing added. http://bit.ly/9Kv86g
FDA Expands Use of Approved Breast Cancer Drug
tweetmeme.com — “The U.S. Food and Drug Administration today approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced breast cancer in postmenopausal women for whom hormonal therapy is indicated.HER2 is a” View full resource at tweetmeme.com
Most Recently Shared on February 2, 2010 at 5:36 pm By:
Healthcare TweetMeme Health Social Media
FDA Expands Use of Approved Breast Cancer Drug http://retwt.me/1LQFf (via @FightPink)
GSK's TYKERB(R) Receives Accelerated Approval For First-Line Combination Treatment Of Metastatic Breast Cancer
medicalnewstoday.com — “GlaxoSmithKline (NYSE: GSK) announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for a new combination regimen using TYKERB® (lapatinib) as a first-line” View full resource at medicalnewstoday.com
Most Recently Shared on February 2, 2010 at 2:10 pm By:
GSK's TYKERB(R) Receives Accelerated Approval For First-Line Combination Treatment Of Metastatic Breast Cancer http://mnt.to/3x4y
Men For A Cause, United Against Breast Cancer: Approval Expanded for Breast Cancer Drug Tykerb - BusinessWeek
mybreastcancerawareness.blogspot.com — “Men For A Cause, United Against Breast Cancer: Approval Expanded for Breast Cancer Drug Tykerb - BusinessWeek” View full resource at mybreastcancerawareness.blogspot.com
Most Recently Shared on February 2, 2010 at 3:30 am By:
Men For A Cause (TM) Health Organization
Approval Expanded for Breast Cancer Drug Tykerb - BusinessWeek: Approval Expanded for Breast… http://goo.gl/fb/ETxE
Men For A Cause, United Against Breast Cancer: Approval Expanded for Breast Cancer Drug Tykerb - BusinessWeek
mybreastcancerawareness.blogspot.com — “Men For A Cause, United Against Breast Cancer: Approval Expanded for Breast Cancer Drug Tykerb - BusinessWeek” View full resource at mybreastcancerawareness.blogspot.com
Most Recently Shared on February 2, 2010 at 3:27 am By:
Men For A Cause (TM) Health Organization
Approval Expanded for Breast Cancer Drug Tykerb - BusinessWeek: Approval Expanded for Breast… http://goo.gl/fb/waaC
FDA Expands Use Of Approved Breast Cancer Drug
medicalnewstoday.com — “The u.s. food and drug administration approved tykerb (lapatinib) in combination with femara (letrozole) to treat hormone positive and her2-positive advanced breast cancer in postmenopausal women ” View full resource at medicalnewstoday.com
Most Recently Shared on February 1, 2010 at 4:14 pm By:
FDA Expands Use Of Approved Breast Cancer Drug http://mnt.to/3x3q #breastcancer
GSK's TYKERB® Receives Accelerated Approval For First-line Combination Treatment Of Hormone Receptor Positive, HER2+/ErbB2+ Breast Cancer
medicalnewstoday.com — “Glaxosmithkline announced that the u.s. food and drug administration (fda) has granted accelerated approval for a new combination regimen using tykerb® (lapatinib) as a first-line, all-oral tr” View full resource at medicalnewstoday.com
Most Recently Shared on January 30, 2010 at 2:06 pm By:
GSK's TYKERB® Receives Accelerated Approval For First-line Combination Treatment Of Hormone Receptor Positive, HER... http://mnt.to/3wZQ
FDA Expands Use of Approved Breast Cancer Drug
fda.gov — “The u.s. food and drug administration today approved tykerb (lapatinib) in combination with femara (letrozole) to treat hormone positive and her2-positive advanced breast cancer in postmenopausal women for whom hormonal therapy is indicated.” View full resource at fda.gov
Most Recently Shared on January 29, 2010 at 11:42 pm By:
FDA Expands Use of Approved Breast Cancer Drug http://bit.ly/by1mT7
Advertisement
